These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 10222364)

  • 1. Evaluation of the measurement of lysate homocysteine in patients with symptomatic arterial disease and in healthy volunteers.
    Brandl R; Probst R; Müller B; Powarzynski S; Maurer PC; Neumeier D
    Clin Chem; 1999 May; 45(5):699-702. PubMed ID: 10222364
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasma folate adequacy as determined by homocysteine level.
    Lewis CA; Pancharuniti N; Sauberlich HE
    Ann N Y Acad Sci; 1992 Sep; 669():360-2. PubMed ID: 1444047
    [No Abstract]   [Full Text] [Related]  

  • 3. Homocysteine: an independent risk factor associated with coronary disease and other arterial occlusive diseases in adults.
    Drown DJ
    Prog Cardiovasc Nurs; 1995; 10(4):37-8. PubMed ID: 8584549
    [No Abstract]   [Full Text] [Related]  

  • 4. Association between erythrocyte mean corpuscular volume and peripheral arterial disease in male subjects: a case control study.
    Mueller T; Haidinger D; Luft C; Horvath W; Poelz W; Haltmayer M
    Angiology; 2001 Sep; 52(9):605-13. PubMed ID: 11570659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased plasma homocysteine concentration in patients with chronic renal failure.
    Chauveau P; Chadefaux B; Coudé M; Aupetit J; Hannedouche T; Kamoun P; Jungers P
    Miner Electrolyte Metab; 1992; 18(2-5):196-8. PubMed ID: 1465057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of moderate hyperhomocysteinemia in patients with early-onset venous and arterial occlusive disease.
    Fermo I; Vigano' D'Angelo S; Paroni R; Mazzola G; Calori G; D'Angelo A
    Ann Intern Med; 1995 Nov; 123(10):747-53. PubMed ID: 7574192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of hyperhomocysteinemia in vascular disease: comparative study of thrombotic venous disease vis-à-vis occlusive arterial disease.
    Bhargava S; Parakh R; Manocha A; Ali A; Srivastava LM
    Vascular; 2007; 15(3):149-53. PubMed ID: 17573020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disturbed ratio of erythrocyte and plasma S-adenosylmethionine/S-adenosylhomocysteine in peripheral arterial occlusive disease.
    Loehrer FM; Tschöpl M; Angst CP; Litynski P; Jäger K; Fowler B; Haefeli WE
    Atherosclerosis; 2001 Jan; 154(1):147-54. PubMed ID: 11137094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of hyperhomocyst(e)inemia in patients with peripheral arterial occlusive disease.
    Malinow MR; Kang SS; Taylor LM; Wong PW; Coull B; Inahara T; Mukerjee D; Sexton G; Upson B
    Circulation; 1989 Jun; 79(6):1180-8. PubMed ID: 2785871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Homocysteine levels and peripheral arterial occlusive disease: a prospective cohort study and review of the literature.
    Asfar S; Safar HA
    J Cardiovasc Surg (Torino); 2007 Oct; 48(5):601-5. PubMed ID: 17989630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma homocysteine and arterial thromboembolic disease.
    Mbewu AD; Nogoduka C; Taylor B
    S Afr Med J; 2003 Mar; 93(3):192-4. PubMed ID: 12768941
    [No Abstract]   [Full Text] [Related]  

  • 12. Arterial stiffness is rapidly induced by raising the plasma homocysteine concentration with methionine.
    Nestel PJ; Chronopoulos A; Cehun M
    Atherosclerosis; 2003 Nov; 171(1):83-6. PubMed ID: 14642409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of plasma homocyst(e)ine in arterial occlusive diseases.
    Malinow MR; Stampfer MJ
    Clin Chem; 1994 Jun; 40(6):857-8. PubMed ID: 8087977
    [No Abstract]   [Full Text] [Related]  

  • 14. Plasma homocysteine and lipoprotein profile in patients with peripheral arterial occlusive disease.
    Rassoul F; Richter V; Janke C; Purschwitz K; Klötzer B; Geisel J; Herrmann W
    Angiology; 2000 Mar; 51(3):189-96. PubMed ID: 10744006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma homocysteine and restenosis after femoropopliteal angioplasty.
    Kovacevic T; Van Der Loo B; Amann-Vesti BR; Rousson V; Koppensteiner R
    J Endovasc Ther; 2004 Jun; 11(3):302-9. PubMed ID: 15174910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mild hyperhomocysteinemia and hemostatic factors in patients with arterial vascular diseases.
    Freyburger G; Labrouche S; Sassoust G; Rouanet F; Javorschi S; Parrot F
    Thromb Haemost; 1997 Mar; 77(3):466-71. PubMed ID: 9065995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No effect of homocysteine-lowering therapy on vascular inflammation and haemostasis in peripheral arterial occlusive disease.
    Schernthaner GH; Plank C; Minar E; Bieglmayer C; Koppensteiner R; Schernthaner G
    Eur J Clin Invest; 2006 May; 36(5):333-9. PubMed ID: 16634837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Don't forget homocystéinemia's screening in young patients with arterial thrombosis].
    Lellouche F; Dorval I; Corvisier JM; Geffroy F; Rouaut G
    Rev Med Interne; 2006 Jan; 27(1):77-8. PubMed ID: 16274874
    [No Abstract]   [Full Text] [Related]  

  • 19. [Relationship between hyperhomocysteinemia and endothelial activation in patients with obliterative arteriopathy of the legs].
    Rogolino A; Farsi A; Brunelli T; Ilari I; Capanni M; Domeneghetti MP; Dorigo W; Lombardi R; Pulli R; Pratesi C; Gensini GF
    Minerva Cardioangiol; 1999 Dec; 47(12):583. PubMed ID: 10670214
    [No Abstract]   [Full Text] [Related]  

  • 20. Thrombophilic genotypes, natural anticoagulants, and plasma homocysteine in myeloproliferative disorders: relationship with splanchnic vein thrombosis and arterial disease.
    Amitrano L; Guardascione MA; Ames PR; Margaglione M; Antinolfi I; Iannaccone L; Annunziata M; Ferrara F; Brancaccio V; Balzano A
    Am J Hematol; 2003 Feb; 72(2):75-81. PubMed ID: 12555209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.